Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Tsunashima

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Case of Gastric Cancer with Mediastinal Lymph Node Recurrence Four Years after Surgery Despite Pathologically Complete Response to Preoperative Chemotherapy]Shigeyoshi Higashi, Haruna Furukawa, Tomohiro Takahashi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2025
Prevalence and molecular landscape of NRG1 fusions in Japanese solid tumors: a nationwide data analysis using the C-CAT databaseMasaki Ishida, Tadaaki Yamada, Ryo Tsunashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2024
[Ascending Colon Cancer with Radical Resection after Stent Reimplantation Due to Colonic Stent Obstruction for Palliation-A Case Report]Kensei Hanaoka, Yoshitoshi Ichikawa, Masakazu Miyake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Bladder Preservation by Neoadjuvant Chemotherapy for Sigmoid Colon Cancer with Bladder Invasion]Shoko Iida, Yoshitoshi Ichikawa, Masakazu Miyake, et al.
Dalton Transactions (Cambridge, England : 2003)|June 12, 2012
Incorporation of cationic electron donor of Ni-pyridyltetrathiafulvalene with anionic electron acceptor of polyoxometalateRyo Tsunashima, Takumi Matsumoto, Norihisa Hoshino, et al.
Oncology Letters|May 1, 2023
Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest<sup>™</sup> 95GC Breast in a multi‑institutional registry studyYasuto Naoi, Ryo Tsunashima, Kenzo Shimazu, et al.
Breast Cancer (Tokyo, Japan)|September 25, 2025
Pathological homogeneity and utility in the genetic diagnosis of paired mirror samples from breast cancer 10G-vacuum-assisted biopsies using a novel longitudinal dividing deviceAkira Watanabe, Sae Kitano, Chikage Kato, et al.
Breast Cancer (Tokyo, Japan)|June 25, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studiesAya Imai, Ryo Tsunashima, Yu Hidaka, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Case of Gastric Cancer with Mediastinal Lymph Node Recurrence Four Years after Surgery Despite Pathologically Complete Response to Preoperative Chemotherapy]Shigeyoshi Higashi, Haruna Furukawa, Tomohiro Takahashi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2025
Prevalence and molecular landscape of NRG1 fusions in Japanese solid tumors: a nationwide data analysis using the C-CAT databaseMasaki Ishida, Tadaaki Yamada, Ryo Tsunashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2024
[Ascending Colon Cancer with Radical Resection after Stent Reimplantation Due to Colonic Stent Obstruction for Palliation-A Case Report]Kensei Hanaoka, Yoshitoshi Ichikawa, Masakazu Miyake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 14, 2025
[A Case of Bladder Preservation by Neoadjuvant Chemotherapy for Sigmoid Colon Cancer with Bladder Invasion]Shoko Iida, Yoshitoshi Ichikawa, Masakazu Miyake, et al.
Dalton Transactions (Cambridge, England : 2003)|June 12, 2012
Incorporation of cationic electron donor of Ni-pyridyltetrathiafulvalene with anionic electron acceptor of polyoxometalateRyo Tsunashima, Takumi Matsumoto, Norihisa Hoshino, et al.
Oncology Letters|May 1, 2023
Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest<sup>™</sup> 95GC Breast in a multi‑institutional registry studyYasuto Naoi, Ryo Tsunashima, Kenzo Shimazu, et al.
Breast Cancer (Tokyo, Japan)|September 25, 2025
Pathological homogeneity and utility in the genetic diagnosis of paired mirror samples from breast cancer 10G-vacuum-assisted biopsies using a novel longitudinal dividing deviceAkira Watanabe, Sae Kitano, Chikage Kato, et al.
Breast Cancer (Tokyo, Japan)|June 25, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studiesAya Imai, Ryo Tsunashima, Yu Hidaka, et al.
Pageof 6